These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29313975)

  • 1. Near-infrared photoimmunotherapy targeting EGFR-Shedding new light on glioblastoma treatment.
    Burley TA; Mączyńska J; Shah A; Szopa W; Harrington KJ; Boult JKR; Mrozek-Wilczkiewicz A; Vinci M; Bamber JC; Kaspera W; Kramer-Marek G
    Int J Cancer; 2018 Jun; 142(11):2363-2374. PubMed ID: 29313975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triggering anti-GBM immune response with EGFR-mediated photoimmunotherapy.
    Mączyńska J; Raes F; Da Pieve C; Turnock S; Boult JKR; Hoebart J; Niedbala M; Robinson SP; Harrington KJ; Kaspera W; Kramer-Marek G
    BMC Med; 2022 Jan; 20(1):16. PubMed ID: 35057796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Near Infrared Photoimmunotherapy Targeting EGFR Positive Triple Negative Breast Cancer: Optimizing the Conjugate-Light Regimen.
    Nagaya T; Sato K; Harada T; Nakamura Y; Choyke PL; Kobayashi H
    PLoS One; 2015; 10(8):e0136829. PubMed ID: 26313651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT).
    Siddiqui MR; Railkar R; Sanford T; Crooks DR; Eckhaus MA; Haines D; Choyke PL; Kobayashi H; Agarwal PK
    Sci Rep; 2019 Feb; 9(1):2084. PubMed ID: 30765854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depatuxizumab Mafodotin (ABT-414)-induced Glioblastoma Cell Death Requires EGFR Overexpression, but not EGFR
    von Achenbach C; Silginer M; Blot V; Weiss WA; Weller M
    Mol Cancer Ther; 2020 Jun; 19(6):1328-1339. PubMed ID: 32371586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Near Infrared Photoimmunotherapy in a Transgenic Mouse Model of Spontaneous Epidermal Growth Factor Receptor (EGFR)-expressing Lung Cancer.
    Nakamura Y; Ohler ZW; Householder D; Nagaya T; Sato K; Okuyama S; Ogata F; Daar D; Hoa T; Choyke PL; Kobayashi H
    Mol Cancer Ther; 2017 Feb; 16(2):408-414. PubMed ID: 28151706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photoimmunotherapy: comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor.
    Sato K; Watanabe R; Hanaoka H; Harada T; Nakajima T; Kim I; Paik CH; Choyke PL; Kobayashi H
    Mol Oncol; 2014 May; 8(3):620-32. PubMed ID: 24508062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer.
    Railkar R; Krane LS; Li QQ; Sanford T; Siddiqui MR; Haines D; Vourganti S; Brancato SJ; Choyke PL; Kobayashi H; Agarwal PK
    Mol Cancer Ther; 2017 Oct; 16(10):2201-2214. PubMed ID: 28619755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABT-414, an Antibody-Drug Conjugate Targeting a Tumor-Selective EGFR Epitope.
    Phillips AC; Boghaert ER; Vaidya KS; Mitten MJ; Norvell S; Falls HD; DeVries PJ; Cheng D; Meulbroek JA; Buchanan FG; McKay LM; Goodwin NC; Reilly EB
    Mol Cancer Ther; 2016 Apr; 15(4):661-9. PubMed ID: 26846818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy.
    Mitsunaga M; Nakajima T; Sano K; Kramer-Marek G; Choyke PL; Kobayashi H
    BMC Cancer; 2012 Aug; 12():345. PubMed ID: 22873679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photoimmunotherapy targeting biliary-pancreatic cancer with humanized anti-TROP2 antibody.
    Nishimura T; Mitsunaga M; Sawada R; Saruta M; Kobayashi H; Matsumoto N; Kanke T; Yanai H; Nakamura K
    Cancer Med; 2019 Dec; 8(18):7781-7792. PubMed ID: 31674732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptor (EGFR) density may not be the only determinant for the efficacy of EGFR-targeted photoimmunotherapy in human head and neck cancer cell lines.
    Peng W; de Bruijn HS; Farrell E; Sioud M; Mashayekhi V; Oliveira S; van Dam GM; Roodenburg JLN; Witjes MJH; Robinson DJ
    Lasers Surg Med; 2018 Jul; 50(5):513-522. PubMed ID: 29777587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near-Infrared Photoimmunotherapy Using a Protein Mimetic for EGFR-Positive Salivary Gland Cancer.
    Yamaguchi H; Suzuki T; Okada Y; Ono J; Sano H; Banba A; Sakata H; Ishikawa A; Morita T
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Early Therapeutic Effects after Near-Infrared Photoimmunotherapy (NIR-PIT) Using Luciferase-Luciferin Photon-Counting and Fluorescence Imaging.
    Maruoka Y; Nagaya T; Nakamura Y; Sato K; Ogata F; Okuyama S; Choyke PL; Kobayashi H
    Mol Pharm; 2017 Dec; 14(12):4628-4635. PubMed ID: 29135265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts.
    Lal B; Goodwin CR; Sang Y; Foss CA; Cornet K; Muzamil S; Pomper MG; Kim J; Laterra J
    Mol Cancer Ther; 2009 Jul; 8(7):1751-60. PubMed ID: 19584231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal Growth Factor Receptor Extracellular Domain Mutations in Glioblastoma Present Opportunities for Clinical Imaging and Therapeutic Development.
    Binder ZA; Thorne AH; Bakas S; Wileyto EP; Bilello M; Akbari H; Rathore S; Ha SM; Zhang L; Ferguson CJ; Dahiya S; Bi WL; Reardon DA; Idbaih A; Felsberg J; Hentschel B; Weller M; Bagley SJ; Morrissette JJD; Nasrallah MP; Ma J; Zanca C; Scott AM; Orellana L; Davatzikos C; Furnari FB; O'Rourke DM
    Cancer Cell; 2018 Jul; 34(1):163-177.e7. PubMed ID: 29990498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Phototherapy for Malignant Pleural Mesothelioma: Near-Infrared Photoimmunotherapy Targeting Podoplanin.
    Nishinaga Y; Sato K; Yasui H; Taki S; Takahashi K; Shimizu M; Endo R; Koike C; Kuramoto N; Nakamura S; Fukui T; Yukawa H; Baba Y; K Kaneko M; Chen-Yoshikawa TF; Kobayashi H; Kato Y; Hasegawa Y
    Cells; 2020 Apr; 9(4):. PubMed ID: 32326079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms and Antitumor Activity of a Binary EGFR/DNA-Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide.
    Sharifi Z; Abdulkarim B; Meehan B; Rak J; Daniel P; Schmitt J; Lauzon N; Eppert K; Duncan HM; Petrecca K; Guiot MC; Jean-Claude B; Sabri S
    Clin Cancer Res; 2019 Dec; 25(24):7594-7608. PubMed ID: 31540977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lycorine inhibits glioblastoma multiforme growth through EGFR suppression.
    Shen J; Zhang T; Cheng Z; Zhu N; Wang H; Lin L; Wang Z; Yi H; Hu M
    J Exp Clin Cancer Res; 2018 Jul; 37(1):157. PubMed ID: 30016965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-dye Conjugates Targeting EGFR and HER2 for the Photoimmunotherapy of Bladder Cancer.
    Huber F; Wolf I; Storz J; Schultze-Seemann S; Lauw S; Klemenz L; Miernik A; Gratzke C; Brückner R; Wolf P
    Anticancer Res; 2024 May; 44(5):1837-1844. PubMed ID: 38677753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.